CARDIFF ONCOLOGY, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CARDIFF ONCOLOGY, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-03-31 was -$1.00K.
- CARDIFF ONCOLOGY, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2011-12-31 was $0.00.
- CARDIFF ONCOLOGY, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was -$1.00K.
- CARDIFF ONCOLOGY, INC. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $0.00.
- CARDIFF ONCOLOGY, INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $0.00.
- CARDIFF ONCOLOGY, INC. stock issued during period, value, conversion of convertible securities for fiscal 2011 was $1.13M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2022-12-31 | -$1.00K 10-K · filed 2024-02-29 | |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-11-02 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.13M 10-K · filed 2014-03-17 |
| 2008-12-31 | $93.64K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |